Skip to main content

Table 4 Frequency of proviral insertions within defined genomic regions

From: Impairment of alternative splice sites defining a novel gammaretroviral exon within gagmodifies the oncogenic properties of Akv murine leukemia virus

Virus

Upstreama

 

Promoterb

 

1. intron

 

Internal intron

 

Last intron

 

Downstreamc

 

Exon

 

Outsided

 

+

-

+

-

+

-

+

-

+

-

+

-

+

-

 

Akv-wt

2/104 2%

7/104 7%

5/104 5%

3/104 3%

9/104 9%

16/104 15%

6/104 6%

17/104 16%

2/104 2%

1/104 1%

5/104 5%

8/104 8%

2/104 2%

1/104 1%

11/104 10%

Akv-CD

3/46 7%

6/46 13%

1/46 2%

0/46 0%

3/46 7%

5/46 11%

2/46 4%

8/46 17%

0/46 0%

0/46 0%

4/46 9%

6/46 13%

1/46 2%

0/46 0%

5/46 11%

Akv-EH

3/51 6%

4/51 8%

1/51 2%

0/51 0%

4/51 8%

6/51 12%

2/51 4%

11/51 22%

2/51 4%

0/51 0%

7/51 14%

1/51 2%

2/51 4%

2/51 4%

6/51 12%

Akv-CDH

1/39 3%

2/39 5%

2/39 5%

3/39 8%

7/39 18%

3/39 8%

3/39 8%

5/39 13%

0/39 0%

1/39 3%

5/39 13%

4/39 10%

0/39 0%

0/39 0%

3/39 8%

Total

9/240 4%

19/240 8%

9/240 4%

6/240 3%

23/240 10%

30/240 13%

13/240 5%

41/240 17%

4/240 2%

2/240 1%

21/240 9%

19/240 8%

5/240 2%

3/240 1%

25/240 10%

  1. a Within 3–100 kb upstream of target gene/RefSeq
  2. b Within 0–3 kb upstream of exon1 of target gene/RefSeq
  3. c Within 100 kb downstream of target gene/RefSeq
  4. d Proviral integrations > 100 kb away from gene/RefSeq
  5. + or - denotes the orientation of the integrated provirus relative to the target gene/RefSeq.